Publications by authors named "Peter Slavny"

Claim this Profile
A
Advancements in mammalian display technology for therapeutic antibody development and beyond: current landscape, challenges, and future prospects.
Peter Slavny, Manjunath Hegde, Achim Doerner, Kothai Parthiban, John McCafferty

Front Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venom.
Line Ledsgaard, Andreas H Laustsen, Urska Pus, Jack Wade, Pedro Villar, Peter Slavny

MAbs· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: 'Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo .
Susan Aungier, Alison J Cartwright, Anja Schwenzer, Jennifer Marshall, Mike R Dyson, Peter Slavny

Ann Rheum Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?
Susan R Aungier, Alison J Cartwright, Anja Schwenzer, Jennifer L Marshall, Michael R Dyson, Peter Slavny

Ann Rheum Dis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies.
Andreas H Laustsen, Aneesh Karatt-Vellatt, Edward W Masters, Ana Silvia Arias, Urska Pus, Peter Slavny

Nat Commun· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies.
Andreas H Laustsen, Aneesh Karatt-Vellatt, Edward W Masters, Ana Silvia Arias, Urska Pus, Peter Slavny

Nat Commun· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from the ligand binding domain.
Danielle M DiCara, Dimitri Y Chirgadze, Anthony R Pope, Aneesh Karatt-Vellatt, Anja Winter, Peter Slavny

Sci Rep· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of PAS domain flanking regions on oligomerisation and redox signalling by NifL.
Richard Little, Peter Slavny, Ray Dixon

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunoglobulin domain of the sodium channel β3 subunit contains a surface-localized disulfide bond that is required for homophilic binding.
Nikitha R Yereddi, Fiona S Cusdin, Sivakumar Namadurai, Len C Packman, Tom P Monie, Peter Slavny

FASEB J· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substitutions in the redox-sensing PAS domain of the NifL regulatory protein define an inter-subunit pathway for redox signal transmission.
Richard Little, Paloma Salinas, Peter Slavny, Thomas A Clarke, Ray Dixon

Mol Microbiol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quaternary structure changes in a second Per-Arnt-Sim domain mediate intramolecular redox signal relay in the NifL regulatory protein.
Peter Slavny, Richard Little, Paloma Salinas, Thomas A Clarke, Ray Dixon

Mol Microbiol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis